Distinct localization and function of 1,4,5IP3 receptor subtypes and the 1,3,4,5IP4 receptor GAP1IP4BP in highly purified human platelet membranes

被引:58
作者
El-Daher, SS
Patel, Y
Siddiqua, A
Hassock, S
Edmunds, S
Maddison, B
Patel, G
Goulding, D
Lupu, F
Wojcikiewicz, RJH
Authi, KS
机构
[1] Thrombosis Res Inst, Platelet Sect, London SW3 6LR, England
[2] SUNY Hlth Sci Ctr, Dept Pharmacol, Syracuse, NY 13210 USA
关键词
D O I
10.1182/blood.V95.11.3412.011k03_3412_3422
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet activation is associated with an increase of cytosolic Ca++ levels. The (IP3)-I-1,4,5 receptors [(IP3R)-I-1,4,5] are known to mediate Ca++ release from intracellular stores of many cell types. Currently there are at least 3 distinct subtypes of (IP3R)-I-1,4,5-type I, type II, and type III-with suggestions of distinct roles in Ca++ elevation. Specific receptors for (IP4)-I-1,3,4,5 belonging to the GAP1 family have also been described though their involvement with Ca++ regulation is controversial. In this study we report that platelets contain all 3 subtypes of (IP3R)-I-1,4,5 but in different amounts. Type I end type II receptors are predominant. In studies using highly purified platelet plasma (PM) and intracellular membranes (IM) we report a distinct localization of these receptors, The PM fractions were found to contain the type III (IP3R)-I-1,4,5 and GAPI1(IP4BP) in cont rast to IM, which contained type I (IP3R)-I-1,4,5. The type II receptor exhibited a dual distribution. In studies examining the labeling of surface proteins with biotin in intact platelets only the type III (IP3R)-I-1,4,5 was significantly labeled. Immunogold studies of ultracryosections of human platelets showed significantly more labeling of the PM with the type III receptor antibodies than with type I receptor antibodies. Ca++ flux studies were carried out with the PM to demonstrate in vitro function of inositol phosphate receptors, Ca++ release activities were present with both (IP3)-I-1,4,5 and (IP4)-I-1,3,4,5 (EC50 = 1.3 and 0.8 mu mol/L, respectively). Discrimination of the Ca++-releasing activities was demonstrated with cyclic adenosine monophosphate (cAMP)-dependent protein kinase (cAMP-PK) specifically inhibiting (IP3)-I-1,4,5 but not (1,3),(IP4)-I-4,5-. induced Ca++ flux. In experiments with both PM and intact platelets, the (1,4,5)IP(3)Rs but not GAP1(IP4BP) were found to be substrates of cAMP-PK and cGMP-PK, Thus the Ca++ flux property of (IP4)-I-1,3,4,5 is insensitive to cAMP-PK, These studies suggest distinct roles for the (IP3R)-I-1,4,5 subtypes in Ca++ movements, with the type III receptor and GAP1(IP4BP) associated with cation entry in human platelets and the type I receptor involved with Ca++ release from intracellular stores. (Blood. 2000;95:3412-3422) (C) 2000 by The American Society of Hematology.
引用
收藏
页码:3412 / 3422
页数:11
相关论文
共 71 条
[41]   Phosphatidylinositol 3,4,5-trisphosphate triggers platelet aggregation by activating Ca2+ influx [J].
Lu, PJ ;
Hsu, AL ;
Wang, DS ;
Chen, CS .
BIOCHEMISTRY, 1998, 37 (27) :9776-9783
[42]  
LUCKHOFF P, 1992, NATURE, V326, P301
[43]   Activation of receptor-operated cation channels via P-2X1 not P-2T purinoceptors in human platelets [J].
MacKenzie, AB ;
MahautSmith, MP ;
Sage, SO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :2879-2881
[44]  
MARSHALL ICB, 1993, J EXP BIOL, V184, P161
[45]  
MENASHI S, 1981, J BIOL CHEM, V256, P4095
[46]   The InsP(3) receptor and intracellular Ca2+ signaling [J].
Mikoshiba, K .
CURRENT OPINION IN NEUROBIOLOGY, 1997, 7 (03) :339-345
[47]   SYNERGISM OF INOSITOL TRISPHOSPHATE AND TETRAKISPHOSPHATE IN ACTIVATING CA-2+-DEPENDENT K+ CHANNELS [J].
MORRIS, AP ;
GALLACHER, DV ;
IRVINE, RF ;
PETERSEN, OH .
NATURE, 1987, 330 (6149) :653-655
[48]  
NAKADE S, 1994, J BIOL CHEM, V269, P6735
[49]  
NEWTON CL, 1994, J BIOL CHEM, V269, P28613
[50]   Isolation of InsP(4) and InsP(6) binding proteins from human platelets: InsP(4) promotes Ca2+ efflux from inside-out plasma membrane vesicles containing 104 kDa GAP1(IP4BP) protein [J].
ORourke, F ;
Matthews, E ;
Feinstein, MB .
BIOCHEMICAL JOURNAL, 1996, 315 :1027-1034